Veracyte
VCYT
50 hedge funds and large institutions have $150M invested in Veracyte in 2014 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
178% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 9
19% more funds holding
Funds holding: 42 → 50 (+8)
8% more capital invested
Capital invested by funds: $140M → $150M (+$10.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
VCYT Hedge Fund Activity: Q2 2014 in Review
50 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2014, worth a combined $150M — up 7.6% from $140M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new VCYT positions and 3 closed out — a net gain of 8 holders — while 25 added to existing stakes and 9 trimmed.
The largest buyer was Pier Capital, opening a new position worth an estimated $2.86M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $3.19M sold.
- 50 institutional investors held Veracyte (VCYT) as of Q2 2014, up from 42 in Q1 2014.
- Funds reported $150M of Veracyte stock for Q2 2014, up 7.6% quarter-over-quarter.
- 11 funds opened new Veracyte positions in Q2 2014 and 3 closed out, a net change of +8 holders.
- The largest Veracyte buyer in Q2 2014 was Pier Capital, an estimated $2.86M added.
- The largest Veracyte seller in Q2 2014 was Alyeska Investment Group, an estimated $3.19M sold.
Based on aggregated 13F filings for Q2 2014.